J
John F. Forbes
Researcher at University of Limerick
Publications - 373
Citations - 51254
John F. Forbes is an academic researcher from University of Limerick. The author has contributed to research in topics: Breast cancer & Tamoxifen. The author has an hindex of 88, co-authored 368 publications receiving 46433 citations. Previous affiliations of John F. Forbes include University of Newcastle & University of Melbourne.
Papers
More filters
Journal ArticleDOI
Selective oestrogen receptor modulators in prevention of breast cancer: an updated meta-analysis of individual participant data
Jack Cuzick,Ivana Sestak,Bernardo Bonanni,Joseph P. Costantino,Steve Cummings,Andrea Decensi,Mitch Dowsett,John F. Forbes,Leslie G. Ford,Andrea Z. LaCroix,John L. Mershon,Bruce H. Mitlak,Trevor J. Powles,Umberto Veronesi,Victor G. Vogel,D. Lawrence Wickerham +15 more
TL;DR: For all SERMs, incidence of invasive oestrogen (ER)-positive breast cancer was reduced both during treatment and for at least 5 years after completion.
Journal ArticleDOI
Goserelin for ovarian protection during breast-cancer adjuvant chemotherapy.
Halle C. F. Moore,Joseph M. Unger,Kelly-Anne Phillips,Frances M. Boyle,Frances M. Boyle,Erika Hitre,David L. Porter,Prudence A. Francis,Lori J. Goldstein,Henry L. Gomez,Carlos S. Vallejos,Ann H. Partridge,Shaker R. Dakhil,Agustin A. Garcia,Julie R. Gralow,Janine M. Lombard,John F. Forbes,Silvana Martino,William E. Barlow,Carol J. Fabian,Lori M. Minasian,Frank L. Meyskens,Richard D. Gelber,Gabriel N. Hortobagyi,Kathy S. Albain +24 more
TL;DR: Although missing data weaken interpretation of the findings, administration of goserelin with chemotherapy appeared to protect against ovarian failure, reducing the risk of early menopause and improving prospects for fertility.
Journal ArticleDOI
Tamoxifen-Induced Reduction in Mammographic Density and Breast Cancer Risk Reduction: A Nested Case–Control Study
Jack Cuzick,Jane Warwick,Elizabeth Pinney,Stephen W. Duffy,Simon Cawthorn,Anthony Howell,John F. Forbes,Ruth Warren +7 more
TL;DR: The 12- to 18-month change in mammographic breast density is an excellent predictor of response to tamoxifen in the preventive setting.
Journal ArticleDOI
Occupation and risk of severe COVID-19: prospective cohort study of 120 075 UK Biobank participants.
Miriam Mutambudzi,Claire Niedwiedz,Ewan B. Macdonald,Alastair H Leyland,Frances S. Mair,Jana Anderson,Carlos Celis-Morales,John G.F. Cleland,John F. Forbes,Jason M.R. Gill,Claire E. Hastie,Frederick K. Ho,Bhautesh Dinesh Jani,Daniel F. Mackay,Barbara I. Nicholl,Catherine A. O'Donnell,Naveed Sattar,Paul Welsh,Jill P. Pell,Srinivasa Vittal Katikireddi,Evangelia Demou +20 more
TL;DR: Essential workers have a higher risk of severe COVID-19, and the need for national and organisational policies and practices that protect and support workers with an elevated risk is underscored.
Journal ArticleDOI
Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V
Marco Colleoni,Zhuoxin Sun,Karen N. Price,Per Karlsson,John F. Forbes,Beat Thürlimann,Lorenzo Gianni,Monica Castiglione,Richard D. Gelber,Alan S. Coates,Aron Goldhirsch +10 more
TL;DR: Patients with ER-positive breast cancer maintain a significant recurrence rate during extended follow-up, and strategies for follow up and treatments to prevent recurrences may be most efficiently applied and studied in patients withER-positive disease followed for a long period of time.